|
Re: Great comments re safety Bear...
|
5
|
Resverlogix Corp.
|
Aug 30, 2018 09:40AM
|
|
Re: Denali Therapeutics Inc. Market Cap. $1.66 Billion today!!!
|
|
BIOASIS TECHNOLOGIES INC
|
Aug 30, 2018 05:27PM
|
|
Re: New publication on ASSURE results
|
5
|
Resverlogix Corp.
|
Aug 30, 2018 10:12PM
|
|
Zenith MD&A posted to SEDAR 8/23/18
|
2
|
Zenith Epigenetics
|
Aug 31, 2018 09:09AM
|
|
Re: Denali Therapeutics Inc. Market Cap. $1.66 Billion today!!!
|
|
BIOASIS TECHNOLOGIES INC
|
Aug 31, 2018 09:28AM
|
|
Re: Denali Therapeutics Inc. Market Cap. $1.66 Billion today!!!
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 31, 2018 12:31PM
|
|
BiOasis on schedule for BioPharm America Presentation Sept 5, 11AM
|
|
BIOASIS TECHNOLOGIES INC
|
Aug 31, 2018 03:15PM
|
|
NYC events
|
5
|
Resverlogix Corp.
|
Aug 31, 2018 03:21PM
|
|
CTAD Asia Alzheimer's Conference Sept 1 & 2
|
11
|
Resverlogix Corp.
|
Sep 01, 2018 09:25AM
|
|
Re: CTAD Asia Alzheimer's Conference Sept 1 & 2
|
10
|
Resverlogix Corp.
|
Sep 01, 2018 09:31AM
|
|
Perspective on # MACE events and timeline to top-line
|
9
|
Resverlogix Corp.
|
Sep 01, 2018 09:53AM
|
|
Re: Perspective on # MACE events and timeline to top-line
|
7
|
Resverlogix Corp.
|
Sep 01, 2018 01:07PM
|
|
Re: Denali Therapeutics Inc. Market Cap. $1.66 Billion today!!!
|
|
BIOASIS TECHNOLOGIES INC
|
Sep 01, 2018 09:43PM
|
|
Modulating ZEN‐3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE.AI, an Artificial Intelligence Platform
|
8
|
Zenith Epigenetics
|
Sep 01, 2018 10:59PM
|
|
Re: Modulating ZEN‐3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE.AI, an Artificial Intelligence Platform
|
5
|
Zenith Epigenetics
|
Sep 02, 2018 12:27PM
|
|
Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
5
|
Zenith Epigenetics
|
Sep 02, 2018 12:42PM
|
|
Re: Vaccinex
|
2
|
BIOASIS TECHNOLOGIES INC
|
Sep 03, 2018 09:13AM
|
|
Re: Vaccinex
|
4
|
BIOASIS TECHNOLOGIES INC
|
Sep 03, 2018 10:59AM
|
|
New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension
|
9
|
Resverlogix Corp.
|
Sep 03, 2018 11:34PM
|
|
Zenith Epigenetics Announces Publication of a Case Study From its Ongoing mCRPC Clinical Study
|
4
|
Zenith Epigenetics
|
Sep 04, 2018 08:52AM
|
